Starting next month, 24 Arizonans living with PTSD will take part in an FDA-approved study using psilocybin — a naturally occurring psychedelic found in certain mushrooms.
It’s the country’s first clinical trial to use whole psilocybin mushrooms, sometimes called magic mushrooms. The participants are firefighters, police officers and veterans. Each will receive a dose of psilocybin to evaluate the therapeutic potential of whole-mushroom psilocybin versus a synthetic version.
The FDA has authorized the administration of the psilocybin to occur in groups of eight, allowing researchers to monitor safety and efficacy. The project is backed by the Arizona Legislature, the Department of Health Services and the Mayo Clinic.
More Health + Medicine news
-
A study by ASU researchers continues to delve into how opioid withdrawal affects the brain. Using mice, they explored the effects of chronic drug usage. -
A parasitic infection that causes severe diarrhea has appeared in 34 states, including Arizona. But Arizona's cases may not be linked to the outbreak in other states. -
Measles continues to spread in the Valley, and Maricopa County officials are warning of potential public exposures in Tempe and Surprise. -
The Arizona Department of Health Services has adopted a policy affirming tribal sovereignty over health data. -
Published by Penguin Random House, Café Gozhóó executive chef Nephi Craig’s hardcover is anything but a cookbook.
